Pietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski, Alina S Gerrie, Catherine Burton, Mark Bower, John Kuruvilla, Silvia Montoto, Pamela McKay, Christopher P Fox, Samuel Milliken, Awachana Jiamsakul, Wendy Osborne, Graham P Collins, Kate Manos, Kim M Linton, Sunil Iyengar, Shireen Kassam, Michelle Poon Limei, David S Kliman, Nicole Wong Doo, Anne-Marie Watson, Pasquale Fedele, Costas K Yannakou, Stewart Hunt, Matthew Ku, Laurie H Sehn, Alexandra Smith, Hanna Renshaw, Alice Maxwell, Qin Liu, Rageshri Dhairyawan, Graeme Ferguson, Keir Pickard, Daniel Painter, Nisha Thakrar, Kevin W Song, Nada Hamad
Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma associated with immunodeficiency, characterized by uncertain treatment approaches and an unfavourable prognosis. We conducted a multicenter, international, retrospective cohort study, aiming to characterize the clinical features, risk factors, and outcomes of patients with PBL. Data were collected from 22 institutions across four countries regarding patients diagnosed with PBL between 1 January 1999 and 31 December 2020. Survival risk factors were analyzed using both univariate and multivariate regression models...
October 13, 2023: Blood